Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
M.K. Exim's board approved its unaudited standalone results for Q2 FY26 (quarter ended 30 Sept 2025) and H1 FY26. Total revenue for Q2 FY26 stood at Rs. 1,843.86 lakhs, down about 17% from Rs. 2,232.16 lakhs in Q2 FY25. Profit after tax for the quarter fell sharply to Rs. 238.30 lakhs (EPS Rs. 0.59) from Rs. 531.26 lakhs (EPS Rs. 1.32) a year ago. For the half-year, revenue grew modestly to Rs. 4,544.57 lakhs vs Rs. 4,275.06 lakhs, with PAT at Rs. 919.66 lakhs vs Rs. 894.08 lakhs. The Cosmetics segment remains the main revenue driver (Rs. 3,848 lakhs in H1). The statutory auditor (Ummed Jain & Co.) issued an unmodified limited review report. However, cash flow from operations turned negative at Rs. (112.32) lakhs in H1 FY26 versus a positive Rs. 496.41 lakhs in H1 FY25, driven mainly by a sharp build-up in inventory.
Sharp Q2 YoY drop in revenue and profit, combined with negative operating cash flow and margin compression, is a negative signal for near-term earnings momentum, though the half-year picture is still slightly positive. Shareholders may watch for whether the Q2 weakness is one-off or a trend, especially given heavy working capital absorption in inventory.